Trial Profile
Long term monitoring of safety in subjects treated with duloxetine for stress urinary incontinence
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jun 2006
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Stress incontinence
- Focus Adverse reactions
- 16 Jun 2006 New trial record.